ReviewJournal of the European Academy of Dermatology and Venereology : JEADV2025
Darier disease: Current insights and challenges in pathogenesis and management.
Review in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Rapid improvement of Darier disease with topical roflumilast: A case report.JAAD case reports · 2026Article
- Darier disease-A review highlighting new insights from the Darier Disease International Task Force.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Review
- Bimekizumab as an Effective Treatment in Darier Disease: Clinical Outcomes of a Single-Center Retrospective Analysis of Patients Treated with Biologics.Dermatology and therapy · 2026Article
- Consensus Recommendations for Management of Darier Disease: A Practical Approach.Dermatology and therapy · 2026Article
- Severe Darier disease complicated by recurrent multidrug-resistant cutaneous infection.JAAD case reports · 2026Article
- Markedly improved disease control in Darier disease (Skin health and disease · 2026Article
- Unexpected remission of Darier disease in a melanoma patient treated with trametinib and naporafenib.JAAD case reports · 2026Article
- Sarco/endoplasmatic reticulum calcium ATPase activity in healthy muscle and Brody disease.Biochemistry and biophysics reports · 2026Article
- Reconsidering Efficacy and Safety: A Critical Appraisal of Repurposing Anti-inflammatory Targeted Drugs in Darier disease.Acta dermato-venereologica · 2026Article
- Secukinumab in Refractory Generalized Darier's Disease with a 40-Year Disease Duration: A Case Report.Clinical, cosmetic and investigational dermatology · 2026Article
- Interleukin (IL)-17A Inhibitor as a Treatment for Darier Disease in the Pediatric Population.Cureus · 2026Article
- Mimicking Darier Disease In Vitro: A Human Epidermal Organoid Approach.Experimental dermatology · 2025Article
- Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.Pharmaceuticals (Basel, Switzerland) · 2025Review
- "Clinical Overlap of Darier's Disease and Acrokeratosis Verruciformis of Hopf": A Case Report.Clinical case reports · 2025Article
- Review
- Darier disease: Current insights and challenges in pathogenesis and management.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Review
- Darier disease: Golden era of discovery and global collaborations.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Article
- Kaposi's Varicelliform Eruption: A Serious and Potentially Fatal Complication of Darier's Disease.Cureus · 2025Article
- Acrokeratosis verruciformis of Hopf: Genetic, clinicopathologic and therapeutic features (Review).Medicine internationalReview
- Darier's Disease Successfully Treated with Tofacitinib: A Case Report.Case reports in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Darier disease is a rare autosomal dominant genodermatosis caused by mutations in the ATP2A2 gene encoding for sarcoendoplasmic reticulum Ca
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.